Publication | Open Access

Inhibitors of acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 1: Hit to lead evaluation of a novel arylsulfonamide series

Medicinal ChemistryPharmaceutical ScienceBiochemistryMedicineNatural SciencesGlycobiologyNovel Arylsulfonamide SeriesAcetyltransferase DomainDrug DevelopmentChemical BiologyPharmacologyPharmaceutical ChemistryDrug DiscoveryGlycosylation